Neumora Therapeutics (NMRA) Shares Outstanding (2022 - 2026)

Neumora Therapeutics has reported Shares Outstanding for 5 years, with the latest figure at $182.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 12.62% year-over-year to $182.2 million; the trailing twelve-month figure through Mar 2026 stood at $182.2 million (up 12.62% YoY), and the FY2025 full-year result was $174.3 million, up 7.76% from the prior year.
• Shares Outstanding for Q1 2026 stood at $182.2 million, up from $174.3 million in the prior quarter.
• The five-year high for Shares Outstanding was $182.2 million in Q1 2026, with the low at $4.5 million in Q4 2025.
• Average Shares Outstanding over 5 years is $117.1 million, with a median of $159.4 million recorded in 2024.
• Year-over-year, Shares Outstanding soared 387.33% in 2024 and grew 0.91% in 2025.
• Tracing NMRA's Shares Outstanding over 5 years: stood at $32.6 million in 2022, then soared by 387.04% to $158.8 million in 2023, then rose by 1.81% to $161.7 million in 2024, then advanced by 7.76% to $174.3 million in 2025, then increased by 4.53% to $182.2 million in 2026.
• The last three Shares Outstanding figures came in at $182.2 million (Q1 2026), $174.3 million (Q4 2025), and $161.9 million (Q3 2025), per Business Quant data.

Peer Comparison